T1	Treatment 76 157	Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab
T2	Treatment 165 236	Paclitaxel-Carboplatin-Bevacizumab Followed byÂ Maintenance Bevacizumab
T3	Treatment 467 551	(pemetrexed-carboplatin-bevacizumab and maintenance pemetrexed-bevacizumab [PemCBev]
T4	Treatment 554 555	.
T5	Treatment 556 629	paclitaxel-carboplatin-bevacizumab and maintenance bevacizumab [PacCBev])
T6	Treatment 898 910	for PemCBev;
T7	Treatment 919 933	versus PacCBev
